Two years after Ebola infection, survivors exhibit specific memory T cell responses against ebolavirus, according to new research presented at ECCMID.
Pseudomonas aeruginosa uses a phage to trick the host’s immune system into ignoring it, in turn suppressing bacterial clearance from infected wounds, according to new research.
A second individual has achieved sustained remission from HIV-1 after ceasing antiretroviral treatment, according to researchers from University College London. Following a hematopoietic stem cell transplant and chemotherapy the patient has had undetectable viral loads for 18 months.
A new study has suggested that sleep causes a dip in Gαs-coupled receptor agonists, in turn improving T cell integrin activation – a process T cells use to target viral cells.
New research has provided evidence that basophils might play an important role in the immune response to bacterial infections, preventing the development of sepsis.
Collaborative research efforts with scientists from Janssen, the Scripps Research Institute, the University of Hong Kong, the University of Pennsylvania and more has led to success in creating a promising novel long-lasting llama-derived antibody therapy for influenza.
A recent study carried out by researchers from the University of Zurich and University Hospital Zurich has discovered that the production of broad acting antibodies is dependent on the genome of the virus.
Guy Thwaites, Director of the Oxford University Clinical Research Unit/Wellcome Program in Vietnam, speaks on neurotuberculosis and the challenges it faces in terms of treatment, HIV co-infection and the political will necessary for change.
Take a look behind the scenes of a recent Future Virology review entitled ‘Antiviral therapeutic approaches for human rhinovirus infections’ as we ask author Peter Barlow about antivirals, antibodies and the host response.
Research presented at ASM Microbe has revealed that Treg cells may be protecting babies from contracting HIV from their mothers in utero.
